Business - CNBC
-
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
-
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
-
Investors and labels are buying into the growing South Asian music business in the U.S.
-
Disney is poised to ramp its already booming advertising business. Rita Ferro is behind the push
-
Will Gen Z be the generation to revive moviegoing?
-
Replimune to resubmit twice-rejected drug for approval after FDA shakeup
-
'Our flavors are on the shelf': The evolution of Asian grocery beyond the 'ethnic aisle'
-
Disney's ABC files early broadcast licenses renewal. FCC Chair vows to 'follow the facts'
-
Costco says it saw 'record-breaking' gas volumes amid rising prices
-
Gap shares tumble 14% as retailer cuts sales guidance after disappointing Old Navy performance
-
American Eagle's Aerie is booming, but its namesake brand is lagging despite Sydney Sweeney ads
-
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
-
More monthly auto loan payments are above $1,000, and most are not for luxury models
-
New York passes Mamdani's pied-a-terre tax. Here's who pays and how much
-
Best Buy stock climbs 15% on earnings beat as retailer aims to reinvigorate sales
-
New '60 Minutes' head Nick Bilton says Paramount's CBS News hired him to pivot the show before ratings decline
-
Kohl's stock spikes 20% as slumping retailer says sales trends are improving
-
Jamie Dimon says JPMorgan Chase could spend $20 billion on acquisition: 'We are on the lookout'
-
Boeing CEO says company met requirements to increase 737 Max production to 47 jets per month
-
Lululemon settles proxy battle with founder Chip Wilson, agrees to two board nominees